// App-Quantinova.ai

POS0357 (2021) : MiRNAs CORRELATE WITH IMPROVEMENT IN DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS ON TUMOUR NECROSIS FACTOR INHIBITORS

Researchers

Presenter

  • T. David

Principal Investigators

  • N. Nair

  • J. Oliver

  • E. Schordan

  • H. Firat

  • K. Hyrich

  • A. Morgan

  • A. G. Wilson

  • J. D. Isaacs

  • D. Plant

  • A. Barton

Medical Centers

  • University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

  • Univ of Manchester, Centre for Musculoskeletal Research, Manchester, United Kingdom

  • Leeds Teaching Hospitals NHS Trust, Yorkshire and North East Genomic Laboratory Hub, Leeds, United Kingdom

  • FIRALIS S.A., CSO (Molecular Diagnostics), Huningue, France

  • FIRALIS S.A., CEO and CSO (Management Team), Huningue, France

  • The University of Manchester, Arthritis Research UK, Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Sciences Centre, Manchester, United Kingdom

  • University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom

  • Leeds Teaching Hospitals NHS Trust and NIHR Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom

  • University College Dublin, UCD School of Medicine and Medical Science, Conway Institute, Dublin, Ireland

  • Newcastle University, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle upon Tyne, United Kingdom

  • Newcastle upon Tyne Hospitals NHS Foundation Trust, Musculoskeletal Unit, Freeman Hospital, Newcastle upon Tyne, United Kingdom

Locations

  • United Kingdom

  • France

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved